Press Releases

Friday, December 21, 2012

BUFFALO, NY — Researchers from Roswell Park Cancer Institute (RPCI) have published findings from a preclinical study assessing the effectiveness of a small-molecule inhibitor, CFAK-Y15, in treating some brain cancers.

Wednesday, December 12, 2012

BUFFALO, NY — DeMarco Ogletree, a cashier in the Nutrition & Food Service Department at Roswell Park Cancer Institute (RPCI), earned the $2,000 Eva M. Noles Scholarship Friday, December 7 at the fifth annual Eva M.

Tuesday, December 4, 2012

BUFFALO, NY — Roswell Park Cancer Institute (RPCI) has been named to The Leapfrog Group’s annual Top Hospitals list for a third consecutive year.

Thursday, November 29, 2012

BUFFALO, NY — Cancer research pioneer Robert A.

Thursday, November 29, 2012

WHAT:           The fifth annual Eva M. Noles Scholarship & Community Recognition Breakfast honoring the legacy of Eva M.

Wednesday, November 21, 2012

BUFFALO, NY — The Roswell Park Cancer Institute (RPCI) community will gather for the annual Tree of Hope lighting ceremony Friday, December 7 from 4:30 p.m. to 6:30 p.m. at RPCI.

Tuesday, November 13, 2012

Representatives from Tops Markets and key event sponsors today presented a check for $180,000 to support cancer research and patient support programs at Roswell Park.

Thursday, November 8, 2012

BUFFALO, N.Y.— Roswell Park Cancer Institute (RPCI) closed out the $40 million Phase I of ‘Making Room to Save Lives: The Campaign to Build a Greater Roswell Park’ today with the announcement of a $1.5 million donation from New Era during a press conferen

Monday, November 5, 2012

(BUFFALO, NY) Giuliana Rancic, star of E!’s Fashion Police and a breast cancer survivor, visited Buffalo today to receive the Gilda Radner Courage Award from Roswell Park Cancer Institute.

Monday, October 29, 2012

BUFFALO — More than 75 percent of Western New York pharmacists say tobacco sales in pharmacies should be legally banned, according to research conducted by Roswell Park Cancer Institute (RPCI) and the University at Buffal

Tuesday, October 23, 2012

BUFFALO — Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.